This article explores China’s landmark advancements in stem cell clinical research by 2025, highlighting breakthroughs in neuroregeneration (e.g., 60% symptom improvement in Parkinson’s trials using mesenchymal stem cells), cardiovascular repair (enhanced myocardial regeneration post-infarction), and autoimmune disease management.
This article examines the physiological reactions, therapeutic improvements, and potential risks of stem cell infusion.
As an active participant in the Second Boao Stem Cell Industry Conference, I witnessed the groundbreaking release of five new
Hainan, China, is rapidly emerging as a hub for medical tourism, particularly in the field of stem cell therapy.
Introduction: The Burden of COPD and the Need for Innovation Chronic Obstructive Pulmonary Disease (COPD) remains a global health crisis,
1. Legally Approved Institutions for Stem Cell Therapy in China As of April 2025, China has made significant strides in
Today, I want to share insights into a landmark case from China and explore how this approach challenges traditional paradigms in PD treatment.
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition characterized by persistent symptoms following an initial COVID-19 infection.
Highlighting cutting-edge advancements, the piece underscores breakthroughs in tissue engineering and minimally invasive techniques that promise faster recovery and targeted healing.
English
Chinese
French
Spanish